标题
PIM1 kinase as a target for cancer therapy
作者
关键词
-
出版物
EXPERT OPINION ON INVESTIGATIONAL DRUGS
Volume 21, Issue 4, Pages 425-436
出版商
Informa Healthcare
发表日期
2012-03-06
DOI
10.1517/13543784.2012.668527
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Pim-1 Kinase Expression Predicts Radiation Response in Squamocellular Carcinoma of Head and Neck and Is under the Control of Epidermal Growth Factor Receptor
- (2015) Katriina Peltola et al. NEOPLASIA
- 7-(4H-1,2,4-Triazol-3-yl)benzo[c][2,6]naphthyridines: A novel class of Pim kinase inhibitors with potent cell antiproliferative activity
- (2011) Fabrice Pierre et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- The discovery of novel benzofuran-2-carboxylic acids as potent Pim-1 inhibitors
- (2011) Yibin Xiang et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Mechanisms of cytotoxicity to Pim kinase inhibitor, SGI-1776, in acute myeloid leukemia
- (2011) L. S. Chen et al. BLOOD
- Targeting PIM kinase enhances the activity of sunitinib in renal cell carcinoma
- (2011) D Mahalingam et al. BRITISH JOURNAL OF CANCER
- Review on clinical trials of targeted treatments in malignant mesothelioma
- (2011) Jan Nyrop Jakobsen et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- The oncogenic kinase Pim-1 is modulated by K-Ras signaling and mediates transformed growth and radioresistance in human pancreatic ductal adenocarcinoma cells
- (2011) D. Xu et al. CARCINOGENESIS
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- High-Throughput Kinase Profiling: A More Efficient Approach toward the Discovery of New Kinase Inhibitors
- (2011) Chandrasekhar V. Miduturu et al. CHEMISTRY & BIOLOGY
- Targeting mTOR Signaling Pathway in Ovarian Cancer
- (2011) S. Mabuchi et al. CURRENT MEDICINAL CHEMISTRY
- Using Insights into Pim1 Structure to Design New Anticancer Drugs
- (2011) Silvia Schenone et al. CURRENT PHARMACEUTICAL DESIGN
- Targeted Therapies for Metastatic Esophagogastric Cancer
- (2011) Deepa Reddy et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- PLK1 as an oncology target: current status and future potential
- (2011) Campbell McInnes et al. DRUG DISCOVERY TODAY
- Discovery of Novel Pim-1 Kinase Inhibitors by a Hierarchical Multistage Virtual Screening Approach Based on SVM Model, Pharmacophore, and Molecular Docking
- (2011) Ji-Xia Ren et al. Journal of Chemical Information and Modeling
- Overexpression of Pim-1 in bladder cancer
- (2011) Shengjie Guo et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Structurally Sophisticated Octahedral Metal Complexes as Highly Selective Protein Kinase Inhibitors
- (2011) Li Feng et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Targeted therapies for thyroid tumors
- (2011) Steven I Sherman MODERN PATHOLOGY
- The proto-oncogene Pim-1 is a target of miR-33a
- (2011) M Thomas et al. ONCOGENE
- ERG Deregulation Induces PIM1 Over-Expression and Aneuploidy in Prostate Epithelial Cells
- (2011) Vera Magistroni et al. PLoS One
- PIM1-Activated PRAS40 Regulates Radioresistance in Non-small Cell Lung Cancer Cells through Interplay with FOXO3a, 14-3-3 and Protein Phosphatases
- (2011) Wanyeon Kim et al. RADIATION RESEARCH
- Aurora kinase inhibitors as anticancer molecules
- (2010) Hiroshi Katayama et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- Identification and structure–activity relationship of 8-hydroxy-quinoline-7-carboxylic acid derivatives as inhibitors of Pim-1 kinase
- (2010) Faten Sliman et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Cancer Statistics, 2010
- (2010) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Hypoxia-inducible proto-oncogene Pim-1 is a prognostic marker in pancreatic ductal adenocarcinoma
- (2010) Carolin Reiser-Erkan et al. CANCER BIOLOGY & THERAPY
- PIM1 Protein Kinase regulates PRAS40 phosphorylation and mTOR activity in FDCP1 cells
- (2010) Fengxue Zhang et al. CANCER BIOLOGY & THERAPY
- Pim 1 kinase inhibitor ETP-45299 suppresses cellular proliferation and synergizes with PI3K inhibition
- (2010) Carmen Blanco-Aparicio et al. CANCER LETTERS
- Drugging the PI3 Kinome: From Chemical Tools to Drugs in the Clinic
- (2010) P. Workman et al. CANCER RESEARCH
- miR-328 Functions as an RNA Decoy to Modulate hnRNP E2 Regulation of mRNA Translation in Leukemic Blasts
- (2010) Anna M. Eiring et al. CELL
- Targeted Cancer Therapies in the Twenty-First Century: Lessons From Imatinib
- (2010) F Stegmeier et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- New potent dual inhibitors of CK2 and Pim kinases: discovery and structural insights
- (2010) Miriam López-Ramos et al. FASEB JOURNAL
- mTOR regulation of autophagy
- (2010) Chang Hwa Jung et al. FEBS LETTERS
- Why target PIM1 for cancer diagnosis and treatment?
- (2010) Nancy S Magnuson et al. Future Oncology
- PIM serine/threonine kinases in the pathogenesis and therapy of hematologic malignancies and solid cancers
- (2010) L. Brault et al. HAEMATOLOGICA
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
- (2010) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Regulation of Skp2 Levels by the Pim-1 Protein Kinase
- (2010) Bo Cen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Overexpression of Pim-1 is associated with poor prognosis in patients with esophageal squamous cell carcinoma
- (2010) Hong-Tao Liu et al. JOURNAL OF SURGICAL ONCOLOGY
- Pim-selective inhibitor DHPCC-9 reveals Pim kinases as potent stimulators of cancer cell migration and invasion
- (2010) Niina M Santio et al. Molecular Cancer
- p53-Dependent Induction of Prostate Cancer Cell Senescence by the PIM1 Protein Kinase
- (2010) M. Zemskova et al. MOLECULAR CANCER RESEARCH
- Aurora Kinase Inhibitors - Rising Stars in Cancer Therapeutics?
- (2010) A. A. Dar et al. MOLECULAR CANCER THERAPEUTICS
- Multifaceted polo-like kinases: drug targets and antitargets for cancer therapy
- (2010) Klaus Strebhardt NATURE REVIEWS DRUG DISCOVERY
- Targeting mTOR: prospects for mTOR complex 2 inhibitors in cancer therapy
- (2010) C A Sparks et al. ONCOGENE
- Hypoxia-Mediated Up-Regulation of Pim-1 Contributes to Solid Tumor Formation
- (2009) Jian Chen et al. AMERICAN JOURNAL OF PATHOLOGY
- Structure-based design of 3-aryl-6-amino-triazolo[4,3-b]pyridazine inhibitors of Pim-1 kinase
- (2009) Ron Grey et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Pim kinase inhibitor, SGI-1776, induces apoptosis in chronic lymphocytic leukemia cells
- (2009) L. S. Chen et al. BLOOD
- Dissection of PIM serine/threonine kinases in FLT3-ITD–induced leukemogenesis reveals PIM1 as regulator of CXCL12–CXCR4-mediated homing and migration
- (2009) Rebekka Grundler et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Discovery of 3H-Benzo[4,5]thieno[3,2-d]pyrimidin-4-ones as Potent, Highly Selective, and Orally Bioavailable Inhibitors of the Human Protooncogene Proviral Insertion Site in Moloney Murine Leukemia Virus (PIM) Kinases
- (2009) Zhi-Fu Tao et al. JOURNAL OF MEDICINAL CHEMISTRY
- Synthesis, Kinase Inhibitory Potencies, and in Vitro Antiproliferative Evaluation of New Pim Kinase Inhibitors
- (2009) Rufine Akué-Gédu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Identification of Tumor-associated Autoantigens for the Diagnosis of Colorectal Cancer in Serum Using High Density Protein Microarrays
- (2009) Ingrid Babel et al. MOLECULAR & CELLULAR PROTEOMICS
- Pharmacologic inhibition of Pim kinases alters prostate cancer cell growth and resensitizes chemoresistant cells to taxanes
- (2009) S. M. Mumenthaler et al. MOLECULAR CANCER THERAPEUTICS
- Pim-1 plays a pivotal role in hypoxia-induced chemoresistance
- (2009) J Chen et al. ONCOGENE
- PIM1 phosphorylates and negatively regulates ASK1-mediated apoptosis
- (2009) J J Gu et al. ONCOGENE
- Crystal Structure of the PIM2 Kinase in Complex with an Organoruthenium Inhibitor
- (2009) Alex N. Bullock et al. PLoS One
- Isoxazolo[3,4-b]quinoline-3,4(1H,9H)-diones as unique, potent and selective inhibitors for Pim-1 and Pim-2 kinases: Chemistry, biological activities, and molecular modeling
- (2008) Yunsong Tong et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Molecular therapy for the treatment of hepatocellular carcinoma
- (2008) T F Greten et al. BRITISH JOURNAL OF CANCER
- Pim Kinases Promote Cell Cycle Progression by Phosphorylating and Down-regulating p27Kip1 at the Transcriptional and Posttranscriptional Levels
- (2008) D. Morishita et al. CANCER RESEARCH
- Extremely Tight Binding of a Ruthenium Complex to Glycogen Synthase Kinase 3
- (2008) G. Ekin Atilla-Gokcumen et al. CHEMBIOCHEM
- Similar Biological Activities of Two Isostructural Ruthenium and Osmium Complexes
- (2008) Jasna Maksimoska et al. CHEMISTRY-A EUROPEAN JOURNAL
- Potential roles for the PIM1 kinase in human cancer – A molecular and therapeutic appraisal
- (2008) Nilesh Shah et al. EUROPEAN JOURNAL OF CANCER
- The PIM1 Kinase Is a Critical Component of a Survival Pathway Activated by Docetaxel and Promotes Survival of Docetaxel-treated Prostate Cancer Cells
- (2008) Marina Zemskova et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Down-regulation of Micro-RNA-1 (miR-1) in Lung Cancer
- (2008) Mohd W. Nasser et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Elevated Levels of Oncogenic Protein Kinase Pim-1 Induce the p53 Pathway in Cultured Cells and Correlate with Increased Mdm2 in Mantle Cell Lymphoma
- (2008) Carol Hogan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Primary Cutaneous Marginal Zone B-Cell Lymphomas Are Targeted by Aberrant Somatic Hypermutation
- (2008) Alexander J.A. Deutsch et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Docking Study Yields Four Novel Inhibitors of the Protooncogene Pim-1 Kinase†
- (2008) Albert C. Pierce et al. JOURNAL OF MEDICINAL CHEMISTRY
- Synthesis and Evaluation of Novel Inhibitors of Pim-1 and Pim-2 Protein Kinases
- (2008) Zuping Xia et al. JOURNAL OF MEDICINAL CHEMISTRY
- Ki67 and PIM1 expression predict outcome in mantle cell lymphoma treated with high dose therapy, stem cell transplantation and rituximab: a Cancer and Leukemia Group B 59909 correlative science study
- (2008) Eric D. Hsi et al. LEUKEMIA & LYMPHOMA
- Real-time quantitative RT-PCR assessment of PIM-1 and hK2 mRNA expression in benign prostate hyperplasia and prostate cancer
- (2008) Hui-chan He et al. MEDICAL ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started